{"data":[{"accessionNo":"0002012383-26-002251","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5218264,"percentOfClass":5.3,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-083589","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2520937,"percentOfClass":2.5,"filedAt":"2026-07-14","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-083589","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2520937,"percentOfClass":2.5,"filedAt":"2026-07-14","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-083589","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2520937,"percentOfClass":2.5,"filedAt":"2026-07-14","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-083589","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1336609,"percentOfClass":1.3,"filedAt":"2026-07-14","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-062527","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Rubric Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":8000000,"percentOfClass":8.06,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-062527","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"David Rosen","reportingCik":null,"personType":"HC,IN","sharesOwned":8000000,"percentOfClass":8.06,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0002012383-26-001716","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4946412,"percentOfClass":4.98,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-037977","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-27","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":5916030,"percentOfClass":6,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-037977","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-27","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":5916030,"percentOfClass":6,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-037977","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-27","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":5916030,"percentOfClass":6,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-037977","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-27","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":5194497,"percentOfClass":5.2,"filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-033875","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":5391440,"percentOfClass":5.4,"filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-033875","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":5391440,"percentOfClass":5.4,"filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-033875","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":"82835W108","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":5391440,"percentOfClass":5.4,"filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-015245","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Rubric Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6200000,"percentOfClass":6.27,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001104659-26-015245","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"David Rosen","reportingCik":null,"personType":"HC,IN","sharesOwned":6200000,"percentOfClass":6.27,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0002012383-26-000722","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671858","issuerName":"ARS Pharmaceuticals, Inc.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5013000,"percentOfClass":5.1,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001346824-25-000011","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001671858","issuerName":"ARS PHARMACEUTICALS, INC.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-29","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":10940977,"percentOfClass":11.1,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001346824-25-000011","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001671858","issuerName":"ARS PHARMACEUTICALS, INC.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-29","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":10940977,"percentOfClass":11.1,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001346824-25-000011","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001671858","issuerName":"ARS PHARMACEUTICALS, INC.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-29","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":10940977,"percentOfClass":11.1,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/spry"},{"accessionNo":"0001346824-25-000011","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001671858","issuerName":"ARS PHARMACEUTICALS, INC.","ticker":"SPRY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-29","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":9958073,"percentOfClass":10.1,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/spry"}],"updatedAt":"2026-11-05T13:22:29.114Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/spry","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}